DRUG · Unmapped registry intervention
Irinotecan and cisplatin
Find medicine records ·
Find other trials using this name
Clinical trial
Phase II Study of Irinotecan and Cisplatin in Extensive-stage Small Cell Lung Cancer
NCT02323737
Drugs and interventions used in this trial
2 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Unmapped registry intervention
Etoposide and cisplatin
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedPhase II Study of Irinotecan and Cisplatin in Extensive-stage Small Cell Lung Cancer
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Extensive-stage Small Cell Lung Cancerunresolved
Interventions
Sponsors & collaborators
Chinese Academy of Medical Scienceslead sponsor
China-Japan Friendship Hospitalcollaborator
Chinese PLA General Hospitalcollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02323737 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.